improving maintenance therapy in aml: exploring the role of idh inhibitors
Published 7 months ago • 144 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
2:03
maintenance therapy in aml
-
2:49
maintenance therapy in aml: agents under investigation and future outlooks
-
0:54
idh inhibitors and the evolving aml treatment paradigm
-
5:11
the frontline treatment strategy for newly diagnosed aml
-
1:59
optimizing the use of flt3 inhibitors in aml: sequencing, post-transplant maintenance & more
-
0:59
idh inhibitors in aml
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
4:29
treatment strategies in older patients with aml
-
5:00
post-transplant maintenance strategies in aml
-
1:03
targeted therapies in newly diagnosed aml: bcl2, flt3 and idh inhibitors
-
1:53
treatment strategies for patients with idh1/2-mutated aml ineligible for intensive chemotherapy
-
1:27
incorporating new technologies into the real-life classification of aml to guide treatment decisions
-
2:45
continuity of care for patients with hematological predispositions to aml
-
1:12
the value of flt3 inhibitors in aml and focus for future trial designs
-
1:22
maintenance therapy in mm: perspectives
-
3:47
why maintenance therapy in aml is unnecessary
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
5:34
updates on maintenance therapies in aml
-
1:58
maintenance therapy strategies to reduce relapse in aml